Protara Therapeutics (TARA) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Protara Therapeutics (TARA) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 40.09% |
| 10 | Protara Therapeutics | 233.03 Mn | 233.03 Mn | - | 57.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.69% |
| Dec 31, 2025 | 23.42% |
| Sep 30, 2025 | 19.15% |
| Jun 30, 2025 | 16.72% |
| Dec 31, 2024 | -112.94% |
| Sep 30, 2024 | 78.06% |
| Jun 30, 2024 | 67.66% |
| Mar 31, 2024 | 97.37% |
| Dec 31, 2023 | 65.44% |
| Sep 30, 2023 | 68.14% |
| Jun 30, 2023 | 78.93% |
| Mar 31, 2023 | 11.49% |
| Dec 31, 2022 | -482.13% |
| Jun 30, 2022 | 32.16% |
| Sep 30, 2021 | -82.64% |
| Jun 30, 2021 | -200.31% |
| Mar 31, 2021 | -2,558.36% |
| Sep 30, 2020 | -58.59% |
| Jun 30, 2020 | -349.86% |
| Mar 31, 2020 | -57.60% |